Recursion Provides Updated Guidance on Clinical Trial Starts

/PRNewswire/ -- Recursion (NASDAQ: RXRX) today provided updated guidance on clinical trial starts: Recursion's leadership team has decided that conducting a...

Related Keywords

Salt Lake City , Utah , United States , Toronto , Ontario , Canada , , Linkedin , Twitter , Cerebral Cavernous Malformation , Neurofibromatosis Type , Familial Adenomatous Polyposis , Recursion Operating System , Recursion Data , Recursion Map , San Francisco Bay , Recursion ,